• Overview
• Target Audience
• Faculty
• Learning Objectives
• CPE Credit
• Recertification Credit
• Hardware and Software Requirements
• Commercial Support
• Fees

These activities have been developed and designed for pharmacists who are planning on sitting for the Board of Pharmacy Specialties (BPS) examination in Pharmacotherapy. Created as a supplement to the 2019 Pharmacotherapy Preparatory Review and Recertification Course, the Updates Plus in Pharmacotherapy Webinar Recording will provide an overview of any major guidelines released between Spring 2019 and October 1, 2019.

Release date: November 7, 2019
ORIGINAL BCPS credit expiration date: May 6, 2020
EXTENDED BCPS credit expiration date: July 1, 2020
ACPE credit expiration date: November 6, 2022

The target audience for Updates Plus in Pharmacotherapy is the pharmacist preparing for the spring administration of the BPS Pharmacotherapy specialty certification examination, for Board-certified Pharmacotherapy Pharmacists (BCPSs) looking to earn recertification credit, and those seeking a review of the latest guidelines and therapeutic updates as they relate to the Pharmacotherapy examination content outline.

Cardiovascular and Renal Outcomes with Diabetes Agents
	Brian K. Irons, Pharm.D., FCCP, BCACP Professor of Pharmacy Practice Texas Tech University Health Sciences Center Lubbock, Texas
The AUGUSTUS Trial and Triple Therapy
	Paul P. Dobesh, Pharm.D., FCCP, BCPS, BCCP Professor of Pharmacy Practice and Science University of Nebraska Medical Center College of Pharmacy Omaha, Nebraska
Role of aspirin in the primary prevention of heart disease
	Shannon Finks, Pharm.D., FCCP, BCPS, BCCP, AHSCP-CHC Professor of Clinical Pharmacy and Translational Science University of Tennessee College of Pharmacy Memphis, Tennessee

Conflicts of Interest

At the end of this activity participants will be able to:

1. Analyze the major trials that have evaluated dual antithrombotic therapy compared to triple antithrombotic therapy for patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI).
2. Integrate the most recent evidence and clinical guidelines for management of patients with AF undergoing PCI.
3. Develop an antithrombotic regimen for patients with AF undergoing PCI.
4. Evaluate current literature on the use of aspirin for primary prevention and identify limitations on current evidence.
5. Select appropriate individuals for who aspirin will provide protection from a cardiovascular event.
6. Distinguish best practices in providing guidance to patients on the use of aspirin for primary prevention.
7. Assess which newer diabetes agents have shown to have an improvement in cardiovascular or renal outcomes in patients with diabetes.
8. Evaluate which patients may benefit most in terms of cardiovascular or renal outcomes.
9. Review characteristics of the first oral glucagon-like peptide 1 agonist.
10. Appraise new clinical trial data supporting the use of a sodium glucose cotransporter 2 inhibitor in patients with heart failure.

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The 2019 Updates Plus in Pharmacotherapy Webinar will provide one session with 2.0 contact hours of continuing pharmacy education credit or 2.0 hours of BCPS recertification credit.

The Universal Activity Number for this webinar is:

0217-0000-19-254-H01-P
2.0 contact hours
Application-based activity

To be eligible to earn ACPE continuing pharmacy education (CPE) credit, participants must purchase the 2019 Updates Plus in Pharmacotherapy Webinar Recording and complete, submit and pass the Web-based posttest by November 6, 2022. Posttests may not be submitted more than one time. Partial credit is not available for this activity.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

The posttest will be made available beginning Thursday, November 7, 2019. To be eligible to earn recertification credit, participants must purchase for the 2019 Updates Plus in Pharmacotherapy Webinar Recording and complete, submit and pass a Web-based posttest by July 1, 2020. Posttests may not be submitted more than one time. Partial credit is not available for this activity.

Posttests submitted before the testing deadline that meet or exceed the passing point will earn recertification credit. Note that the passing point for this product will be established in February 2020, based on analysis of the test items by content experts. Once the passing point is known, recertification credits will be forwarded to BPS for those who passed the posttest and the credits will be assigned as of the date of posttest submission.

Questions regarding the number of hours required for recertification should be directed to BPS at (202) 429-7591 or www.bpsweb.org. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

To access the webinar recording by a computer, you will need broadband Internet access, an updated Internet browser, Adobe Flash Player, and speakers or headphones for audio. To access the webinars on a Wi-Fi enabled mobile device, you will need a wireless internet connection and the Adobe Connect App, a free app which can be downloaded from Apple’s App Store or Google Play. Participants who experience difficulty in accessing a webinar should contact ACCP by e-mail at [email protected] or by phone at (913) 492-3311.

The recordings of the session will be made available Thursday, November 14, 2019.

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity

*If you have purchased a 2019 Pharmacotherapy Preparatory Review and Recertification Course product please call us at (913) 492-3311 to receive discount pricing.